In general all childhood cancers are regarded as rare. Therefore it is vital that young patients are referred to specialized pediatric centers for their treatment. The care of children with cancer has dramatically improved over the last 30 years. This improvement in survival is primarily a result of national clinical trials. We are one of the nationally recognized children's hospitals that participates in clinical trials through the efforts of Children's Oncology Group (COG.)
Within childhood cancers, rare tumors account for 15% of all cancers in patients younger
than age 20 and for 30% of all tumors in patients ages 15 to 19. The Rare Tumor Program at Cohen Children’s Medical Center provides state of the art clinical care for children with cancer. It is a comprehensive program that provides a multidisciplinary team of experts who collaborate in the care of each patient and the development and execution of cutting-edge clinical trials to improve outcomes for these patients.
Our program provides and coordinates the expertise of physicians from medical, surgical, orthopedic and radiation oncology, diagnostic radiology, surgical pathology and oncology nursing. The group has extensive expertise in the treatment of rare tumors, such as hepatoblastoma and hepatocellular carcinoma (liver tumors), germ cell tumors (tumors of the reproductive organs), sarcomas of the soft tissues and many other rare cancers including certain tumors that occur primarily in adolescents and young adults, such as esophageal cancer, adrenocortical carcinoma, melanoma, nasopharyngeal carcinoma and thyroid cancer.